Amedisys to Present at the Bank of America Merrill Lynch Health Care Conference

Amedisys to Present at the Bank of America Merrill Lynch Health Care Conference  BATON ROUGE, La., May 7, 2014 (GLOBE NEWSWIRE) -- Amedisys, Inc. (Nasdaq:AMED), one of America's leading healthcare at home companies, today announced that Ronald A. LaBorde, President and Interim Chief Executive Officer, and Dale E. Redman, Interim Chief Financial Officer, will present at the 2014 Bank of America Merrill Lynch Health Care Conference in Las Vegas, NV on Wednesday, May 14, 2014.  The presentation will begin at 11:20 a.m. Pacific/2:20 p.m. Eastern. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com.  About Amedisys:  Amedisys, Inc. (Nasdaq:AMED) is a leading healthcare at home company delivering personalized home health and hospice care to more than 360,000 patients each year. More than 2,200 hospitals and 61,900 physicians nationwide have chosen Amedisys as a partner in post-acute care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based recovery and rehabilitation after an operation or injury, care focused on empowering them to manage a chronic disease, palliative care for those with a terminal illness, or hospice care at the end of life. Amedisys also has the industry's first-ever nationwide Care Transitions program, designed to reduce unnecessary hospital readmissions through patient and caregiver health coaching and care coordination, which starts in the hospital and continues throughout completion of the patient's home health plan of care. For more information about the Company, please visit: http://www.amedisys.com.  We use our company website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations" subpage of our website, which is accessible by clicking on the tab labeled "Investors" on our website home page. We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC") disclosing the same information. In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings") free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation, Nominating and Corporate Governance, Quality of Care and Compliance and Ethics Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance").  CONTACT: Amedisys, Inc.          David Castille          Director, Treasury/Finance          225.299.3665          david.castille@amedisys.com  Amedisys, Inc. logo  
Press spacebar to pause and continue. Press esc to stop.